Who Paid My Doc
Extension
Research payments
$4,447,075
Through program year 2024, $4,447,075 in research payments was reported against Extension, across 2,121 payments.
- Paid by (largest first)
- Boehringer Ingelheim Pharmaceuticals, Inc.; Boehringer Ingelheim Pharma GmbH & Co.KG
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $302,805 | 20 |
| 2023 | Research | $616,320 | 54 |
| 2022 | Research | $730,528 | 64 |
| 2021 | Research | $514,076 | 607 |
| 2020 | Research | $823,556 | 630 |
| 2019 | Research | $1,459,789 | 746 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Teng Moua Rochester, MN Named on 76 payments
- Tracy Luckhardt Birmingham, AL Named on 58 payments
- Maureen Mayes Houston, TX Named on 58 payments
- Virginia Steen Washington, DC Named on 57 payments
- Hyun Kim Minneapolis, MN Named on 54 payments
- Laura Hummers Baltimore, MD Named on 53 payments
- Kristin Highland Cleveland, OH Named on 52 payments
- Brian Morrissey Sacramento, CA Named on 52 payments
- Lawrence Ho Seattle, WA Named on 52 payments
- Mary Scholand Salt Lake City, UT Named on 51 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.